Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention

Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention

Introduction: There is some controversy over the efficacy of statins for the prevention of contrastinduced nephropathy (CIN). There have also been reports on varying efficacies of different statins. Hence, in this study the efficacy of atorvastatin and rosuvastatin for the prevention of CIN was asse...

Full description

Bibliographic Details
Main Authors: Ata Firouzi, Ali Kazem Moussavi, Ahmad Mohebbi, Mohammad Javad Alemzadeh-Ansari, Reza Kiani, Hamid Reza Sanati, Bahram Mohebbi, Farshad Shakerian, Ali Zahedmehr, Mohammad Mostafa Ansari-Ramandi, Saeed Oni Heris, Bahar Ghaleshi, Fatemeh Ghorbani
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2018-09-01
Series:Journal of Cardiovascular and Thoracic Research
Subjects:
contrast-induced nephropathy
statin
percutaneous coronary intervention
Online Access:https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-10-149.pdf

Internet

https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-10-149.pdf

Similar Items